Emelie Schepp is a self-made success story. Schepp self-published her debut novel, MARKED FOR LIFE, and went on to break records for self-published book sales in Sweden. Now an internationally-bestselling author, Schepp delivers her newest thriller to American audiences this June. SLOWLY WE DIE may be part of the Jana Berzelius series, but much of this book reads like a stand-alone. Shifting focus away from Jana’s personal backstory and towards a new - and chilling - case, SLOWLY WE DIE will be largely accessible to readers who have never dipped into this series before. Perhaps most interesting, though, is the decision by Schepp to take her Nordic thriller away from the traditional layered plotting and slow-burn pacing of Scandinavian crime, and towards a more commercial, brisk tone. With crimes plaguing the medical community at the center of this story, fans of medical thrillers by Tess Gerritsen and Patricia Cornwell are likely to be the audience best suited to Schepp’s story of decades-old vendettas in Sweden.